DAIICHI SANKYO, INC.

Lobbying for DAIICHI SANKYO INC

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$130,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

CHRISTOPHER CUNNINGHAM New on this filing

Previously held: US House, Staff, Mike Thompson 2016-2017; LC and LA Elizabeth Esty 2017-2019; LA Ben McAdams 2019-2021; SLA Susan Wild 2021-2022

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 946
ORPHAN Cures Act
HR 2319
Women and Lung Cancer Research and Preventive Services Act of 2025

Lobbying activity 4

Health Issues

Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act reintroduction Issues related to most-favored-nation and other foreign reference drug pricing policy Issues related to the Food and Drug Administration

Taxation/Internal Revenue Code

Discussions regarding tax reform and tariffs

Medicare/Medicaid

Issues related to the Medicare Drug Price Negotiation Program

Issues related to intellectual property rights

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.